Mounjaro Prescription in Sherman, Texas at DFWPMA

Looking for a Mounjaro prescription in Sherman, Texas? Mounjaro (tirzepatide) is a prescription medication for type 2 diabetes that requires careful medical evaluation because inappropriate prescribing or inadequate monitoring can lead to serious health complications.

At DFW Physicians Medical Associates (DFWPMA), our endocrinology and primary care providers conduct comprehensive evaluations of diabetes, metabolic health, medical history, and treatment risks to determine whether Mounjaro is safe and appropriate.

DFWPMA offers Mounjaro prescription evaluations in Sherman and can prescribe Mounjaro to eligible patients when medically appropriate. Mounjaro is FDA-approved to improve blood sugar control in adults and children aged 10 years and older with type 2 diabetes.

Book an appointment online or call (903) 957-0082 to contact our Sherman location.
Address: 📍
425 N Highland Ave., Suite 260, Sherman, TX 75092

Click here to get directions

We accept many major insurance plans. Not sure if your plan is accepted?

Call (903) 957-0082 and our team can help verify coverage.

Why Choose DFWPMA for a Mounjaro Prescription in Sherman, Texas?

DFW Physicians Medical Associates provides Mounjaro prescription evaluations in Sherman through medical providers experienced in endocrinology, diabetes care, metabolic disorders, and chronic disease management. Our multispecialty approach supports individualized diabetes treatment and ongoing medical supervision.

Patients seeking a Mounjaro prescription at DFWPMA can benefit from:

  • Experienced Medical Providers: Access to endocrinology and primary care providers experienced in diabetes management, metabolic health, and medication evaluations.
  • Comprehensive Eligibility Assessment: Evaluation of diabetes status, medical history, current medications, and potential contraindications before prescribing Mounjaro.
  • Diabetes and Metabolic Health Evaluation: Assessment of blood glucose, hemoglobin A1c, kidney function, and other relevant metabolic indicators.
  • Individualized Prescription Decisions: Treatment recommendations based on diabetes management goals, medication history, clinical risks, and overall health.
  • Medication Safety Screening: Review of contraindications and precautions involving thyroid cancer history, pancreatitis, gastrointestinal disorders, gallbladder disease, and other relevant conditions.
  • Dosage Management and Monitoring: Gradual dose adjustments, medication tolerance assessments, and monitoring for potential side effects.
  • Long-Term Diabetes Management: Ongoing evaluation of blood sugar control, metabolic health, treatment effectiveness, and chronic disease management.
  • Coordinated Multispecialty Care: Access to additional medical and behavioral health services when patients require comprehensive support for diabetes-related health concerns.

Mounjaro is not appropriate for every patient with type 2 diabetes. Prescribing decisions require evaluating glycemic control, potential adverse effects, contraindications, and alternative diabetes medications.

At DFWPMA Sherman, comprehensive medical evaluation and individualized treatment planning are central to determining whether Mounjaro is an appropriate diabetes medication.

Schedule an appointment with DFWPMA Sherman to discuss Mounjaro prescription eligibility and your diabetes treatment options.

Meet Our Mounjaro Prescription Providers in Sherman, Texas

DFWPMA Sherman offers Mounjaro prescription evaluations through providers whose clinical expertise includes endocrinology, primary care, diabetes management, and metabolic disorders. These providers can assess medical eligibility and determine whether Mounjaro is appropriate.

Gitana Staskus, MD – Endocrinology

Dr. Gitana Staskus is a board-certified endocrinologist with more than 20 years of clinical experience diagnosing and treating endocrine and metabolic disorders in adults and older adults.

Her expertise includes type 1 and type 2 diabetes, gestational diabetes, weight management, metabolic disorders, thyroid conditions, hormone disorders, and osteoporosis. Dr. Staskus emphasizes individualized treatment planning, patient education, and long-term management of endocrine conditions.

Her specialized background in diabetes and metabolic health is particularly relevant for patients seeking Mounjaro prescription evaluations, including individuals with type 2 diabetes and additional metabolic conditions.

Aniwelyn Tan, DNP – Primary Care

Aniwelyn Tan is an experienced primary care provider with more than 20 years of healthcare experience, including extensive experience managing chronic medical conditions and cardiovascular health concerns.

Her clinical expertise includes diabetes management, obesity, weight management, hypertension, internal medicine, and chronic disease treatment. She provides primary care for patients ages 15 and older.

Her experience in diabetes care and metabolic health supports Mounjaro prescription evaluations, including assessing glycemic control, reviewing medication safety, and developing individualized treatment plans.

Ayodya Perera, MD – Family Medicine

Dr. Ayodya Perera is a family medicine physician providing comprehensive primary care, preventive healthcare, and chronic disease management for patients ages 15 and older.

Dr. Perera’s clinical interests include diabetes management, weight management, hypertension, preventive medicine, and individualized medical treatment. The physician emphasizes shared decision-making and patient-centered healthcare.

This background in diabetes and chronic disease care is relevant to Mounjaro prescription evaluations, including reviewing blood sugar control, treatment eligibility, medication history, and long-term diabetes management goals.

Book an appointment online to inquire about Mounjaro prescription evaluations with DFWPMA’s medical providers in Sherman.

What Can a Mounjaro Prescription in Sherman, Texas Help With?

Mounjaro (tirzepatide) is a weekly GIP and GLP-1 receptor agonist approved to improve blood sugar control in patients aged 10 years and older with type 2 diabetes. It also commonly produces weight loss, although Mounjaro is not specifically approved for chronic weight management.

At DFWPMA Sherman, Mounjaro prescription evaluations address:

  • Type 2 Diabetes Management: Improving blood sugar control in eligible patients with type 2 diabetes.
  • Elevated Hemoglobin A1c: Lowering A1c levels that exceed individualized diabetes treatment goals.
  • Insulin Resistance: Improving glucose regulation in patients with type 2 diabetes through glucose-dependent hormonal effects.
  • Blood Sugar Regulation: Reducing elevated blood glucose through GIP and GLP-1 receptor activation.
  • Weight Changes Associated With Treatment: Supporting appetite reduction and potential weight loss as treatment effects.
  • Complex Diabetes Treatment Needs: Evaluating Mounjaro when existing diabetes medications provide insufficient glycemic control.
  • Diabetes With Additional Metabolic Conditions: Managing type 2 diabetes alongside obesity, hypertension, or high cholesterol.

Mounjaro activates GIP and GLP-1 receptors, increasing glucose-dependent insulin secretion, reducing glucagon levels, and slowing gastric emptying. These effects improve blood sugar control in patients with type 2 diabetes.

The American Academy of Family Physicians recognizes tirzepatide as an effective noninsulin treatment option for type 2 diabetes, with treatment selection based on patient needs, medication benefits, and potential risks.

Source: American Academy of Family Physicians – Management of Type 2 Diabetes Mellitus With Noninsulin Pharmacotherapy

Mounjaro is not indicated for type 1 diabetes and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN2. Important risks include pancreatitis, gastrointestinal complications, dehydration, gallbladder disease, and hypoglycemia when combined with certain diabetes medications.

Patients seeking tirzepatide primarily for chronic weight management should discuss medications specifically approved for that purpose, such as Zepbound.

Source: American College of Physicians – Pharmacologic Treatments for Overweight and Obesity

Schedule an appointment to discuss Mounjaro prescription eligibility at DFWPMA Sherman.

What Mounjaro Prescription Services Are Available at DFWPMA Sherman?

DFWPMA Sherman provides Mounjaro prescription evaluations, diabetes and metabolic testing, medication safety reviews, treatment planning, and ongoing monitoring through endocrinology and primary care providers.

Our Mounjaro prescription services include:

  • Initial Mounjaro Prescription Evaluation: Reviewing medical history, diabetes status, and treatment eligibility.
  • Diabetes and Metabolic Testing: Checking A1c, blood glucose, kidney function, and relevant metabolic markers.
  • Medication and Contraindication Review: Identifying medication interactions, contraindications, and potential health risks.
  • Mounjaro Prescription and Treatment Planning: Prescribing Mounjaro when medically appropriate and establishing diabetes management goals.
  • Starting Dose and Titration: Adjusting dosage according to prescribing guidance, treatment response, and tolerance.
  • Side Effect Monitoring: Assessing gastrointestinal symptoms, dehydration, and other adverse reactions.
  • Blood Sugar and Treatment Response Monitoring: Tracking glucose control, A1c changes, and medication effectiveness.
  • Long-Term Diabetes and Metabolic Care: Managing diabetes, cardiovascular risk factors, and related chronic conditions.
  • Alternative Diabetes Medication Evaluation: Considering other approved medications when Mounjaro is unsuitable.
  • Follow-Up and Coordinated Care: Providing continued medical supervision and specialty referrals when needed.

Mounjaro typically starts at 2.5 mg once weekly for four weeks, followed by 5 mg weekly. Further adjustments depend on treatment response, tolerance, and prescribing guidance. The initial dose is intended for treatment initiation rather than full glycemic control.

Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. Severe abdominal pain, significant dehydration, or allergic reactions require prompt medical attention.

The American Academy of Family Physicians emphasizes individualized diabetes medication selection based on effectiveness, safety, comorbidities, and patient treatment goals.

Source: American Academy of Family Physicians – Management of Type 2 Diabetes Mellitus With Noninsulin Pharmacotherapy

Not every patient qualifies for Mounjaro. A medical evaluation determines whether the medication or an alternative diabetes treatment is appropriate.

Looking for a Mounjaro prescription in Sherman, Texas? Book an appointment or call (903) 957-0082 to schedule your evaluation at DFWPMA.